Gene expression profiling of laterally spreading tumors by unknown
RESEARCH ARTICLE Open Access
Gene expression profiling of laterally
spreading tumors
Shoko Minemura1, Takeshi Tanaka1, Makoto Arai1*, Kenichiro Okimoto1, Arata Oyamada1, Keiko Saito1,
Daisuke Maruoka1, Tomoaki Matsumura1, Tomoo Nakagawa1, Tatsuro Katsuno1, Takashi Kishimoto2
and Osamu Yokosuka1
Abstract
Background: Laterally spreading tumors (LSTs) are generally defined as lesions >10 mm in diameter, are characterized
by lateral expansion along the luminal wall with a low vertical axis. In contrast to other forms of tumor, LSTs are
generally considered to have a superficial growth pattern and the potential for malignancy. We focused on this
morphological character of LSTs, and analyzed the gene expression profile of LSTs.
Methods: The expression of 168 genes in 41 colorectal tumor samples (17 LST-adenoma, 12 LST-carcinoma,
12 Ip [pedunculated type of the Paris classification)-adenoma, all of which were 10 mm or more in diameter] was
analyzed by PCR array. Based on the results, we investigated the expression levels of genes up-regulated in
LST-adenoma, compared to Ip-adenoma, by hierarchical and K-means clustering. To confirm the results of the
array analysis, using an additional 60 samples (38 LST-adenoma, 22 Ip-adenoma), we determined the localization
of the gene product by immunohistochemical staining.
Result: The expression of 129 genes differed in colorectal tumors from normal mucosa by PCR array analysis. As a
result of K-means clustering, the expression levels of five genes, AKT1, BCL2L1, ERBB2, MTA2 and TNFRSF25, were
found to be significantly up-regulated (p < 0.05) in LST-adenoma, compared to Ip-adenoma. Immunohistochemical
analysis showed that the BCL2L1 protein was significantly and meaningfully up-regulated in LST-adenoma compared to
Ip-adenoma (p = 0.010). With respect to apoptosis status in LST-Adenoma, it assumes that BCL2L1 is anti-apoptotic
protein, the samples such as BCL2L1 positive and TUNEL negative, or BCL2L1 negative and TUNEL positive are consistent
with the assumption. 63.2 % LST-adenoma samples were consistent with the assumption.
Conclusions: LSTs have an unusual profile of gene expression compared to other tumors and BCL2L1 might be
concerned in the organization of LSTs.
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Background
Colorectal tumors can be morphologically divided into
three groups on the basis of their microscopic appearance:
protruded-type, depressed-type and laterally spreading-
type tumors [1, 2]. Although the protruded-type (polyp-
oid) tumor has been the major focus of study, recently,
the latter two types of tumor have received attention, not
only from Japanese [3, 4] but also Westerners gastroente-
rologists [2, 5–7]. These two types of tumor have been
reported to be the most difficult lesions to detect by
endoscopic examination and to have the risk of being
cancerous at the time of diagnosis. Although laterally
spreading-type and depressed- type tumors progress in
depth rather than spreading across the surface of the mu-
cosa, the gene expression profile underlying the morpho-
logical pattern has not been determined.
Laterally spreading tumors (LSTs) are generally defined
as lesions >10 mm in diameter, are characterized by lateral
expansion along the luminal wall with a low vertical axis
[3] and are usually divided into two types, granular-type
(Gr-LST) and flat- or nongranular-type (NGr-LST), based
on morphological differences determined endoscopically
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[7]. Gr-LST are composed of superficially spreading aggre-
gates of nodules forming flat, broad-based lesions with a
granulonodular and uneven surface, whereas NGr-LST are
lesions with a flat, smooth surface without granulonodular
features [2].
In this study, we aimed to determine the gene expression
profile of LSTs, specifically, which genes are up or down
regulated in comparison to polypoid tumors, and to identify
the biological pathways involved, such as apoptosis, inva-
sion, metastasis, cell cycling and signal transduction.
Methods
Sample collection and extraction of RNA
A total of 41 colorectal tumor samples resected by ESD
(endoscopic submucosal dissection) or EMR (endoscopic
mucosal dissection) from September 2011 to June 2013 at
the Chiba University Hospital were selected for this study.
The morphological classification and original pathological
diagnoses were 17 LST-adenoma, 12 LST-carcinoma, and
12 Ip-adenoma, all 10 mm or more in diameter. Tumor
and normal mucosa tissues were taken from the same pa-
tient during endoscopic treatment and incubated in RNA
later® (Ambion, Inc., Austin, Texas USA) for 48 h at 4 °C,
and then stored at −80 °C. Total RNA was extracted using
TRIzol reagent (Invitrogen Co., Carlsbad, CA, USA)
according to the manufacturer’s instructions and stored
at −80 °C until further use. This study was approved by the
ethics committee of Chiba University and written informed
consent was obtained from all patients (UMIN 000009998).
PCR array analysis
RNA samples were reversed transcribed using RT2 First
Strand Kits (SA Biosciences Corp., Frederick, MD, USA).
The resulting cDNA was analyzed using the Human
Cancer Pathway and Human Extracellular Matrix &
Adhesion Molecules RT2 Profiler™ PCR Arrays (SA
Biosciences Corp.), which comprises a panel of 84 primer
sets related to genes involved in the cytoskeleton, cell pro-
liferation, cell-cell interactions and cell-matrix interac-
tions. We examined 168 genes in total.
All results were normalized relative to expression of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). PCR
arrays were analyzed using the 7300RT-PCR System
(AB Applied Biosciences). The amplification protocol
consisted of an initial denaturation at 95 °C for 10 min,
followed by 40 cycles of denaturation at 95 °C for 15 s,
and annealing and extension at 60 °C for 1 min. The ex-
pression of each gene was quantified based on its Ct (cycle
threshold), the number of cycles at which the linear phase
crossed the threshold level.
Gene expression data analysis
Statistical analysis of the PCR array data was performed
using an online analysis tool (SA Biosciences Corp.,
http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php),
with statistical significance set at p ≤ 0.05. Relative changes
in gene expression on quantitative RT-PCR were analyzed
using the ΔCt or ΔΔCt method. Data were normalized by
subtracting the average Ct value of the reference gene
(GAPDH) from that of the sample genes in each group
(17 LST-adenoma, 12 LST-carcinoma, 12 Ip-adenoma),
with the normalized Ct value designated the ΔCt value for
that gene. ΔCt was compared to control samples using the
equation ΔΔCt = (ΔCt sample –ΔCt control) and fold
changes in target gene expression were calculated using
the formula, expression fold change = 2(−ΔΔCt).
Hierarchical and K-means clustering analysis
To demonstrate statistical significant difference in gene ex-
pression between LSTs and polypoid tumors, based on the
results of PCR array analysis, we performed comparative
statistical analyses, such as hierarchical and K-means clus-
tering analysis, using GeneSpring GX 12.0 (Agilent) soft-
ware (Chemical Evaluation and Research Institute, Saitama,
Japan). Expression levels of 129 genes (the remaining 39
genes did not yield statistically efficient results in the PCR
array analysis) in the 41 colorectal tumor samples were ana-
lyzed by hierarchical clustering. Based on these results, we
performed K-means clustering to clarify the nature of gene
expression in LSTs.
Immunohistochemistry
To confirm the gene expression, immunohistochemical
analysis was performed on 60 additional samples obtained
from ESD or EMR for colorectal tumors from May 2003
to April 2013 at the Chiba University Hospital. These
comprised 38 LST-adenoma and 22 Ip-adenoma samples.
Sections of colorectal tumors resected by ESD or EMR
were fixed and stained with hematoxylin-eosin for histo-
logical examination. We used the following antibodies:
TNFRSF25, AKT1, BCL2L1, MTA2 and ERBB2 (1:200,
Abcam plc., Cambridge, UK). Positively stained cells were
visualized using 3’3-diaminobenzidine and counterstained
with Mayer’s hematoxylin. Immunoreactivity was inde-
pendently evaluated by two researchers who were blinded
to patient outcome and pathology. We took the brown-
colored cytoplasm cells as positive expressions. When
more than half of cells showed the immunoreactive stains
in one high power field, we judged as “positive” in this
field. Then we selected nine high power fields randomly
and judged each field respectively. If “positive” in more
than half of fields was detected, we ultimately judged as
“positive”. When there was any discrepancy in their evalua-
tions, the samples were reexamined by both researchers.
Evaluation of Apoptosis status in LST-Adenoma
To evaluate the apoptosis status in LST-adenoma, 38
LST-adenoma samples were analyzed by the terminal
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deoxynucleotidyl transferase (TdT)-mediated biotinylated
deoxyuridine-triphosphate nick-end labeling (TUNEL)
method. Apoptotic cell were identified by In situ Apop-
tosis Detection Kit (Takara Bio Inc., Shiga, Japan). TUNEL
positivity was indicated by homogeneously brown nuclear
staining. The apoptotic index was defined as the number
of TUNEL-positive cells in randomly selected nine high
power fields. When the apoptotic index was more than
nine, we ultimately judged as “positive”.
Statistical analysis
All results are expressed as means ± SD. Statistical diffe-
rences between two groups were determined by Student’s
t-test using SPSS 16.0 J (SPSS Inc., Chicago,IL, USA), with
p < 0.05 considered statistically significant.
Results
Clinical characteristics of tumor samples
The 29 LSTs samples were from 15 males (51.7 %) and 14
females (48.3 %), of mean age 69.3 ± 11.8 years, and the
mean tumor size was 23.1 ± 12.8 mm. In terms of location
of LST, 16 (55.2 %) were located in the proximal portion
(3 in cecum, 8 in ascending colon, 5 in transverse colon)
and 13 (44.8 %) were located in the distal portion (2 in the
descending colon, 4 in the sigmoid colon, 7 in the rectum).
According to histological classification, 17 samples were
adenoma and 12 were adenocarcinoma. The 12 polypoid
tumor samples were from 10 males (83.3 %) and 2 females
(16.7 %), of mean age 64.0 ± 13.1 years, and the mean
tumor size was 16.3 ± 9.0 mm. Five (41.7 %) were located
in the proximal portion (1 in the cecum, 4 in the ascen-
ding colon) and 7 (58.3 %) were located in the distal por-
tion (1 in the descending colon, 4 in the sigmoid colon, 2
in the rectum) (Table 1).
Gene expression analysis by PCR array
The 129 genes which were expressed in colorectal
tumors at a significantly different level (unpaired t-test,
p < 0.05) to that of normal mucosa, and the ratios of
their expression levels compared to normal mucosa
(mean ± SD), are listed in the supplementary table
(Additional file 1: Table S1).
Hierarchical and K-means clustering
We performed hierarchical clustering using the gene
expression data produced by PCR array analysis. The 41
colorectal tumor samples were divided into three large
groups. Group 1 mainly consists of LST-adenoma and
Ip-adenoma. Group 2 mainly consists of LST-adenoma.
Group 3 mainly consists of LST-carcinoma (Fig. 1). By
K-means clustering, the expression levels of five genes,
AKT1, BCL2L1, ERBB2, MTA2 and TNFRSF25, were
seen to be significantly up-regulated (p <0.05) in LST-
adenoma compared to Ip-adenoma (Fig. 2).
Immunohistochemical staining
Immunohistochemical staining showed that BCL2L1 and
TNFRSF25 proteins were significantly up-regulated in LST-
adenoma, compared to Ip-adenoma (p = 0.010, p < 0.001).
Of the LST-adenomas, 25 (66 %) were BCL2L1 positive
and 38 (100 %) were TNFRSF25 positive. On the other
hand, of the IP-adenomas, 7 (32 %) were BCL2L1 positive
and 10 (45 %) were TNFRSF25 positive (Table 2). BCL2L1
protein expression was localized in the cytoplasm of the
tumor cells (Fig. 3). There was no difference between
LST-adenoma and Ip-adenoma in expression of the other
proteins, AKT1, MTA2, and ERBB2. We did not get
meaningful immunohistochemical staining patterns for
the AKT1 and ERBB2 proteins but the MTA2 protein was
found to be up-regulated in both LST-Adenoma and
Ip-Adenoma compared to normal mucosa. In high grade
adenoma, 14 out of 20 LST cases (70 %) showed high
expression of BCL2L1 by IHC, on the contrary, only 7 out
of 17 Ip adenoma cases (41 %) showed high expression of
it (p = 0.078, chi-squared test).
Apoptosis status in LST-Adenoma
In 38 LST-adenoma, 7 (18.4 %) sample was TUNEL
positive. It assumes that BCL2L1 is anti-apoptotic pro-
tein, the samples such as BCL2L1 positive and TUNEL
negative, or BCL2L1 negative and TUNEL positive are
consistent with the assumption. We pathologically clas-
sified into high-grade dysplasia and low-grade dysplasia
of 38 LST-adenoma. In 18 high-grade LST-adenoma, ten
were BCL2L1 positive and TUNEL negative and two were
BCL2L1 negative and TUNEL positive. In 20 low-grade
LST-adenoma, ten were BCL2L1 positive and TUNEL
negative, two were BCL2L1 negative and TUNEL positive.
Table 1 Baseline clinical characteristics of the patients whose
tumors were used for PCR array analysis
Characteristics LST Ip
No. of samples 29 12
Age (years) (mean ± SD) 69.3 ± 11.8 64.0 ± 13.1








Tumor size (mm) (mean ± SD) 23.1 ± 12.8 16.3 ± 8.9
Histological type
Adenoma/Carcinoma 17/12 12/0




Fig. 1 (See legend on next page.)
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In summary, 22(63.2 %) samples were consistent with
the assumption.
Discussion
The morphological features of tumors are closely related
to their growth patterns [8]. Polypoid tumors are believed
to exhibit a predominantly vertical growth pattern, rather
than a horizontal growth pattern, while non-polypoid tu-
mors are believed to exhibit the opposite pattern, resulting
in horizontal growth. Although there are some reports
that LSTs have distinct biological characteristics compared
to polypoid tumors [9, 10], the mechanism by which the
LST conformation is generated remains unknown.
LSTs are believed to have distinct characteristics in
terms of histological and genetic features [11]. Several
molecular characteristics of LSTs have been described,
including alteration of the adenomatous polyposis coli
(APC) gene or β-catenin [12–14] affecting the WNT/
APC/β-catenin signaling pathway, mutation of v-Ki-ras2
Kirsten rat sarcoma viral oncogene homolog (KRAS)
[12, 15–20]. However, the molecular background of LSTs
has remained largely unknown [19, 21]. Most of these
studies have targeted genetic and/or epigenetic changes,
or analyzed limited sets of genes. Our study is the first to
clarify the gene expression profile by array analysis which
could clarify the expression of many genes all at once. In
addition, to avoid the effect of size, we used Ip type
tumors with a diameter of 10 mm or more.
We performed immunohistochemical analysis of up-
regulated genes which were show by PCR array on addi-
tional LSTs and polypoid tumors, the expression levels
of BCL2L1 in the LSTs were significantly higher than the
polypoid tumors. This gene belongs to the Bcl-2 family
whose members mainly comprise anti- or pro-apoptotic
regulators that are involved in a wide variety of cellular
activities [22, 23]. BCL2L1 proteins are involved in the
regulation of the mitochondrial pathway of apoptosis by
controlling the production of reactive oxygen species
and release of cytochrome c from mitochondria, both of
which are potent inducers of apoptosis.
The growth of tumors represents an imbalance between
cell proliferation and cell death [24]. There are some re-
ports of analysis of cell proliferation markers, such as Ki-67
[25], apoptosis [26] and apoptosis related proteins, in
(See figure on previous page.)
Fig. 1 Hierarchical Clustering of Expression Levels in Colon Tumors. Expression levels of 129 genes in 41 colorectal tumor samples were analyzed
by hierarchical clustering (distance metric: Peason Uncentered, linkage rule; Average). L-adenoma, LST-adenoma; L-carcinoma, LST-carcinoma;
P-adenoma, Ip-adenoma. These samples were divided into 3 clusters. Group 1 consists of LST-adenomas and Ip-adenomas, Group 2 mainly
consists of LST-adenomas and Group 3 mainly consists of LST-carcinomas
Fig. 2 The mRNA Expression Level in Colon Adenoma. The ratios of mRNA expression level in adenomas compared to normal mucosa corrected
by glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were shown. White bars indicated LST-adenoma and dotted bars indicated Ip-adenoma.
*p < 0.01, unpaired t-test. AKT1, v-akt murine thymoma viral oncogene homolog 1; BCL2L1, B cell leukemia/lymphoma 2-like1; ERBB2, v-erb-b2
avian erythroblastic leukemia viral oncogene homolog 2; MTA2, metastasis associated 1 family, member 2; TNFRSF25, tumor necrosis factor
receptor superfamily, member 25
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colorectal tumors [27]. Kikuchi et al. also reported that the
proliferative activity increased in adenomas with high-grade
dysplasia and carcinomas among colorectal tumors, while
apoptotic activity correspondingly increased in adenomas
but significantly decreased in carcinomas [28]. Ki-67 is one
of the reliable markers of cell cycle in adenoma or cancer
cells. And apoptosis also involved in clinical or morpho-
logical characteristics of tumor. In fact, in a previous study,
the expression levels of Ki-67 and Bcl-2 antigen in adeno-
matous colorectal polyps showed a good correlation [29].
Together with our results and other markers, it might lead
to further understanding the pathophysiology of LST.
It is difficult to claim the significant difference of gene
expressions determined the morphological features of
LSTs. We analyzed the apoptosis status in LST-adenomas
because BCL2L1 worked as anti-apoptosis and the apop-
tosis status in adenoma was less complex than cancer. As
a result, BCL2L1 expression was related to apoptosis sta-
tus in LST-adenoma samples. Our study based on PCR
Array analysis and IHCs was merely not so much the ana-
lysis of gene function as the expression levels of mRNA
and protein. Therefore, further study to clarify the relation
between the gene function and clinical or morphological
characteristics of LST has been needed. Similarly to us,
Suzuki et al. reported that differences in both expression
of anti-apoptotic gene Bcl-2 expression and apoptosis may
play an important role in the morphogenesis of colorectal
neoplasia [30]. Yamada et al. in non-polypoid colorectal
adenomas (non-PAs), significant differences between
apoptosis in the upper and lower portions of lesions sug-
gests that vertical growth in non-PAs seems to be inhibi-
ted by apoptosis. Consequently, horizontal growth comes
to dominate over vertical growth, resulting in the laterally
spreading morphology of non-PAs [31]. Based on these re-
ports, we suggest that anti-apoptotic gene Bcl-2 which
have differential gene expression between LSTs-adenoma
and Ip-adenoma may play an important role in the mor-
phogenesis of LSTs by being responsible for apoptotic ex-
pression. Our analysis for apoptosis and gene expression
has some limitations. We did not clarify the relation bet-
ween BCL2L1 and apoptosis directly in LST, and did not
perform other methods except TUNNEL assay. And we
could not show the question which the inverse correlation
between BCL2L1 and apoptosis in LST is occurred also in
other types of tumor. Further analysis is needed. In the
hierarchical clustering, cancer cases were not separated
from adenoma ones perfectly. We suggested that a small
number of genes analyzed by PCR array might cause this
contingent result.
According to our IHC analysis, TNFRSF25 protein
was also up-regulated in LST-adenoma, compared to
Ip-adenoma (p < 0.001). However, of the Ip-adenomas,
10 (45 %) were TNFRSF25 positive. Up-regulation of
TNFRSF25 is not specific in LST-adenomas. Therefore,
we speculated that the importance of TNFRSF25 ex-
pression was less than that of BCL2L1.
Conclusions
High expression level of apoptosis related genes, such as
BCL2L1, might act as a trigger that determines tumor
morphogenesis and be one of the genes responsible for
horizontal growth, resulting in the laterally spreading
morphology of LSTs.





LST positive/negative Ip positive/negative
TNFRSF25 38/0 10/12 <0.001
AKT1 5/33 4/18 0.414
BCL2L1 25/13 7/15 0.010
MTA2 38/0 22/0 -
ERBB2 2/36 0/22 0.274
Fig. 3 Immunohistochemical analysis of BCL2L1 expression in LST- and Ip-adenoma. a Positive expression in LST-adenoma (×100). b Negative
expression in Ip-adenoma (×100)
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